Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
Authors:
- MD Anderson Head and Neck Cancer Symptom Working GroupMGMD Anderson Head and Neck Cancer Symptom Working Group
- Salman A. ErajSESalman A. Eraj
- Mona K. JomaaMona K. Jomaa
- Crosby D. RockCRCrosby D. Rock
- Abdallah S. R. MohamedAbdallah S. R. Mohamed
- Blaine D. SmithBSBlaine D. Smith
- Joshua B. SmithJSJoshua B. Smith
- Theodora BrowneTBTheodora Browne
- Luke C. CookseyLCLuke C. Cooksey
- Bowman WilliamsBWBowman Williams
- Brandi TempleBTBrandi Temple
- Kathryn E. PrestonKPKathryn E. Preston
Open Access
- 9 September 2017
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 12 (1) , 1-10
Abstract
Given the potential for older patients to experience exaggerated toxicity and symptoms, this study was performed to characterize patient reported outcomes in older patients following definitive radiation therapy (RT) for oropharyngeal cancer (OPC). Cancer-free head and neck cancer survivors (>6 months since treatment completion) were eligible for participation in a questionnaire-based study. Participants completed the MD Anderson Symptom Inventory-Head and Neck module (MDASI-HN). Those patients ≥65 years old at treatment for OPC with definitive RT were included. Individual and overall symptom severity and clinical variables were analyzed. Of the 79 participants analyzed, 82% were male, 95% white, 41% T3/4 disease, 39% RT alone, 27% induction chemotherapy, 52% concurrent, and 18% both, and 96% IMRT. Median age at RT was 71 yrs. (range: 65–85); median time from RT to MDASI-HN was 46 mos. (2/3 > 24 mos.). The top 5 MDASI-HN items rated most severe in terms of mean (±SD) ratings (0–10 scale) were dry mouth (3.48 ± 2.95), taste (2.81 ± 3.29), swallowing (2.59 ± 2.96), mucus in mouth/throat (2.04 ± 2.68), and choking (1.30 ± 2.38) reported at moderate-severe levels (≥5) by 35, 29, 29, 18, and 13%, respectively. Thirty-nine % reported none (0) or no more than mild (1–4) symptoms across all 22 MDASI-HN symptoms items, and 38% had at least one item rated as severe (≥7). Hierarchical cluster analysis resulted in 3 patient groups: 1) ~65% with ranging from none to moderate symptom burden, 2) ~35% with moderate-severe ratings for a subset of classically RT-related symptoms (e.g. dry mouth, mucus, swallowing) and 3) 2 pts. with severe ratings of most items. The overall long-term symptom burden seen in this older OPC cohort treated with modern standard therapy was largely favorable, yet a higher symptom group (~35%) with a distinct pattern of mostly local and classically RT-related symptoms was identified.Keywords
Funding Information
- Stiefel Oropharyngeal Research Fund of the University of Texas MD Anderson Cancer Center Charles and Daneen Stiefel Center for Head and Neck Cancer
- Family of Paul W. Beach
- National Institutes of Health (1R01DE025248-01, 1R01DE025248-01, 1R01DE025248-01, R03 CA188162)
- National Institutes of Health (1R01DE025248-01)
- National Science Foundation (NSF 1557679)
- National Cancer Institute (R01CA214825-01)
- Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program (P50CA097007-10)
- Paul Calabresi Clinical Oncology Program Awards (K12 CA088084-06)
This publication has 25 references indexed in Scilit:
- The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity‐modulated radiotherapy eraCancer, 2016
- Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported OutcomesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data BaseCancer, 2016
- Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment studyRadiotherapy and Oncology, 2015
- The Role of Transoral Robotic Surgery in the Management of Oropharyngeal Squamous Cell Carcinoma: a Current ReviewCurrent Oncology Reports, 2015
- Management of the lymph node‐positive neck in the patient with human papillomavirus‐associated oropharyngeal cancerCancer, 2014
- Human Papillomavirus Prevalence in Oropharyngeal Cancer before Vaccine Introduction, United StatesEmerging Infectious Diseases, 2014
- Intensity-Modulated Radiotherapy is Associated With Improved Global Quality of Life Among Long-term Survivors of Head-and-Neck CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck moduleHead & Neck, 2007
- Radiation therapy for early-stage carcinoma of the oropharynxInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004